| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |